Skip to main content
. 2019 May 30;8(6):523. doi: 10.3390/cells8060523

Table 4.

Proportion of patients with endoscopic improvement at week 6 (ITT Population).

IBD98-M 0.8 g/day (N = 17) IBD98-M 1.2 g/day (N = 16) Placebo (N = 18)
Endoscopic improvement at Week 6 n (%) 5 (29.4) 2 (12.5) 4 (22.2)
95% confidence interval 15.2, 72.3 1.8, 42.8 8.4, 58.1
p value versus Placebo 0.683 0.648

Abbreviations: ITT = intent-to-treat; UCDAI = Ulcerative Colitis Disease Activity Index.